Hargroves Thomas Jeffrey
Director
- Shares
- 97,276
- Price
- $5.04
- Value
- $490,271
CING
No net buyers or sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found 4 CEO/CFO purchases over 12 months.
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
$0.00
0 buyers · 0 sellers
12-month purchases
$667,392
5 distinct insiders
12-month sales
$0.00
0 distinct insiders
Highlighted alerts
10
0 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
4 executive purchases found
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
CING overview: breakout setup, X sentiment and insiders in one page →
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
The option was granted pursuant to the terms of Dr. Silva's Employment Agreement, as amended.
Voluntary purchases and sales; administrative noise stays hidden.
Hargroves Thomas Jeffrey
Director
Hargroves Thomas Jeffrey
Director
Werth Peter J.
Director
Werth Peter J.
Director
Callahan Jennifer L.
SVP and CFO
Callahan Jennifer L.
SVP and CFO
Schaffer Shane J.
Chief Executive Officer
Schaffer Shane J.
Chief Executive Officer
Brams Matthew
EVP and Chief Medical Officer
Brams Matthew
EVP and Chief Medical Officer
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Feb 13, 2026 | Hargroves Thomas Jeffrey Director | Purchase | 97,276 | $5.04 | $490,271 | |
| Feb 13, 2026 | Hargroves Thomas Jeffrey Director | Purchase | 77,821 | $0.10 | $7,782 | |
| Feb 06, 2026 | Werth Peter J. Director | Purchase | 19,455 | $5.04 | $98,053 | |
| Feb 06, 2026 | Werth Peter J. Director | Purchase | 15,564 | $0.10 | $1,556 | |
| Feb 06, 2026 | Callahan Jennifer L. SVP and CFO | Purchase | 4,864 | $5.04 | $24,515 | |
| Feb 06, 2026 | Callahan Jennifer L. SVP and CFO | Purchase | 3,891 | $0.10 | $389.10 | |
| Feb 06, 2026 | Schaffer Shane J. Chief Executive Officer | Purchase | 6,809 | $5.04 | $34,317 | |
| Feb 06, 2026 | Schaffer Shane J. Chief Executive Officer | Purchase | 5,447 | $0.10 | $544.70 | |
| Feb 06, 2026 | Brams Matthew EVP and Chief Medical Officer | Purchase | 1,946 | $5.04 | $9,808 | |
| Feb 06, 2026 | Brams Matthew EVP and Chief Medical Officer | Purchase | 1,556 | $0.10 | $155.60 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.